ProBioGen and Abcuro signed GlymaxX®-Improved Cell Line Development and GMP Production Agreement
ProBioGen AG, a premier service and technology provider for complex therapeutic antibodies and glycoproteins, today announced the closing of a services and license agreement with Abcuro, Inc. Pursuing a new generation of immune modulatory…